Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2017

01-03-2017 | Case Report

Recurrence of a pT2N0cM0 Lower Third Gastric Cancer with No. 6 Lymph Node Micrometastasis after R0 Extended Surgery. Should Adjuvant Therapy be Performed in Conventionally Node-Negative but Micrometastasis-Positive pT2 Gastric Cancer?

Authors: Konstantinos Blouhos, Konstantinos A. Boulas, Konstantinos Tsalis, Nikolaos Barettas, Michail Aftzoglou, Anestis Hatzigeorgiadis

Published in: Journal of Gastrointestinal Cancer | Issue 1/2017

Login to get access

Excerpt

D2 lymphadenectomy has been established as the standard procedure for the prevention of lymph node recurrence in resectable stage IB–III gastric cancer. Nevertheless, R0 resection after optimal D2 dissection did not always prevent disease recurrence; one of the key causative factors is lymph node micrometastasis [1]. The seventh TNM classification of malignant tumors clearly stated that micrometastases in regional and distant lymph nodes detected by morphological techniques (serial sectioning combined with H-E staining and immunohistochemistry) should be reported and calculated in the staging of the disease (pN1mi and pM1 LYM+). However, no definitive criteria for examination of lymph nodes micrometastasis were provided [2]. Furthermore, the seventh edition of TNM classification for gastric cancer and the third Japanese classification of gastric carcinoma did not incorporate lymph node micrometastasis in pN categorization and staging [3, 4]. …
Literature
1.
go back to reference Marano L, Polom K, Patriti A, Roviello G, Falco G, Stracqualursi A, et al. Surgical management of advanced gastric cancer: an evolving issue. Eur J Surg Oncol. 2016;42:18–27.CrossRefPubMed Marano L, Polom K, Patriti A, Roviello G, Falco G, Stracqualursi A, et al. Surgical management of advanced gastric cancer: an evolving issue. Eur J Surg Oncol. 2016;42:18–27.CrossRefPubMed
2.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C. International union against cancer (IUCC) TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2010. Sobin LH, Gospodarowicz MK, Wittekind C. International union against cancer (IUCC) TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2010.
3.
go back to reference Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer. Cancer. 2011;117:2371–8.CrossRefPubMed Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer. Cancer. 2011;117:2371–8.CrossRefPubMed
4.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
5.
go back to reference Arigami T, Uenosono Y, Yanagita S, Nakajo A, Ishigami S, Okumura H, et al. Clinical significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol. 2013;20:515–21.CrossRefPubMed Arigami T, Uenosono Y, Yanagita S, Nakajo A, Ishigami S, Okumura H, et al. Clinical significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol. 2013;20:515–21.CrossRefPubMed
6.
go back to reference Griniatsos J, Michail O, Dimitriou N, Karavokyros I. Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: their clinical significance. World J Gastrointest Oncol. 2012;4:16–21.CrossRefPubMedPubMedCentral Griniatsos J, Michail O, Dimitriou N, Karavokyros I. Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: their clinical significance. World J Gastrointest Oncol. 2012;4:16–21.CrossRefPubMedPubMedCentral
7.
go back to reference Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40:584–91.CrossRefPubMed Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014;40:584–91.CrossRefPubMed
8.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
9.
go back to reference Blouhos K, Boulas KA, Hatzigeorgiadis A. Bursectomy in gastric cancer surgery: surgical technique and operative safety. Updates Surg. 2013;65:95–101.CrossRefPubMed Blouhos K, Boulas KA, Hatzigeorgiadis A. Bursectomy in gastric cancer surgery: surgical technique and operative safety. Updates Surg. 2013;65:95–101.CrossRefPubMed
10.
go back to reference Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A. Right-sided bursectomy as an access plane for aesthetic resection of the posterior leaf of the lesser sac from the head of the pancreas en-block with the No. 6 and 14v lymph nodes in advanced lower-third gastric cancer. Surgery. 2015;158:1742.CrossRefPubMed Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A. Right-sided bursectomy as an access plane for aesthetic resection of the posterior leaf of the lesser sac from the head of the pancreas en-block with the No. 6 and 14v lymph nodes in advanced lower-third gastric cancer. Surgery. 2015;158:1742.CrossRefPubMed
11.
go back to reference Sobin LH, Wittekind C. International Union against Cancer. TNM classification of malignant tumours (6th ed). New York: Wiley-Liss; 2002. Sobin LH, Wittekind C. International Union against Cancer. TNM classification of malignant tumours (6th ed). New York: Wiley-Liss; 2002.
12.
go back to reference Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002;9:771–4.CrossRefPubMed Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002;9:771–4.CrossRefPubMed
13.
go back to reference Jeuck TL, Wittekind C. Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases. Gastric Cancer. 2015;18:100–8.CrossRefPubMed Jeuck TL, Wittekind C. Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases. Gastric Cancer. 2015;18:100–8.CrossRefPubMed
14.
go back to reference Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol. 2001;8:158–62.CrossRefPubMed Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol. 2001;8:158–62.CrossRefPubMed
15.
go back to reference Li Y, Du P, Zhou Y, Cheng Q, Chen D, Wang D, et al. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a meta-analysis of observational studies. J Surg Res. 2014;191:413–22.CrossRefPubMed Li Y, Du P, Zhou Y, Cheng Q, Chen D, Wang D, et al. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a meta-analysis of observational studies. J Surg Res. 2014;191:413–22.CrossRefPubMed
16.
go back to reference Lee CM, Cho JM, Jang YJ, Park SS, Park SH, Kim SJ, et al. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol. 2015;22:765–71.CrossRefPubMed Lee CM, Cho JM, Jang YJ, Park SS, Park SH, Kim SJ, et al. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol. 2015;22:765–71.CrossRefPubMed
17.
go back to reference Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, et al. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res. 2010;162:177–83.CrossRefPubMed Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, et al. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res. 2010;162:177–83.CrossRefPubMed
18.
go back to reference Zeng YJ, Zhang CD, Dai DQ. Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis. World J Gastroenterol. 2015;2:1628–35.CrossRef Zeng YJ, Zhang CD, Dai DQ. Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis. World J Gastroenterol. 2015;2:1628–35.CrossRef
19.
Metadata
Title
Recurrence of a pT2N0cM0 Lower Third Gastric Cancer with No. 6 Lymph Node Micrometastasis after R0 Extended Surgery. Should Adjuvant Therapy be Performed in Conventionally Node-Negative but Micrometastasis-Positive pT2 Gastric Cancer?
Authors
Konstantinos Blouhos
Konstantinos A. Boulas
Konstantinos Tsalis
Nikolaos Barettas
Michail Aftzoglou
Anestis Hatzigeorgiadis
Publication date
01-03-2017
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2017
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9811-y

Other articles of this Issue 1/2017

Journal of Gastrointestinal Cancer 1/2017 Go to the issue